Rebecca Stevenson, Anson Vo, Katherine Markoulis and Nanette Dela Cruz Lacson from Renal Research
Linda Pallot, Vascular Surgery Research
case of a 20-year-old man with leukemia who joined a clinical trial and was treated with WU- CART-007, an “off the shelf” immune system cell product that has undergone extensive genetic engineering to fight cancer. In dermatology, Dr Rebecca Saunderson gave insights into the various conditions her department treated and the positive feedback they had received from patients on both commercial and investigator-led clinical trials. Dr Barbara Lucas presented research that investigated parents administering ultra-early intervention physiotherapy to pre-term and infants at high risk of cerebral palsy or motor delays. While it was found to have no clinically worthwhile effects, the parents perceived the
treatment as beneficial to their babies. Meanwhile, Dr Brendan Neuen highlighted the international impact the renal department’s research had had on dialysis and Type 2 diabetes care over the past decade, and their ongoing work, which includes 50 patients enrolled in 20 randomised trials. Dr Matti Gild gave an overview of the many trials running in endocrinology, including those for bone and thyroid cancers. As part of the International Clinical Trials day events, a display was staged in the RNSH foyer involving several research trial teams. The display offered the chance to highlight the diverse range of trials underway and engage with the community.
Clinical trial researchers at RNSH
WWW.NSLHD.HEALTH.NSW.GOV.AU
5
Made with FlippingBook - professional solution for displaying marketing and sales documents online